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Abstract
Lysyl oxidase (LOX) is an amine oxidase that is critical for the stability of connective tissues. The
secreted proLOX is enzymatically quiescent and is activated through proteolytic cleavage between
residue Gly162 and Asp163 (residue numbers according to the mouse LOX) by bone
morphogenetic protein (BMP)-1 gene products. Here we report a novel processing of proLOX
identified in vitro and in vivo. Two forms of mature LOX were identified and characterized by
their immunoreactivity to specific antibodies, amine oxidase activity and mass spectrometry. One
form was identified as a well characterized BMP-1 processed LOX protein. Another was found to
be a truncated form of LOX (tLOX) resulting from the cleavage at the carboxy terminus of
Arg192. The tLOX still appeared to retain amine oxidase activity. The results from the proLOX
gene deletion and mutation experiments indicated that the processing occurs independent of the
cleavage of proLOX by BMP-1 gene products and likely requires the presence of LOX propeptide.
These results indicate that proLOX could be processed by two different mechanisms producing
two forms of active LOX.
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The formation of covalent intermolecular cross-linking is the final post-translational
modification of collagen, and is crucial for the stability and maintenance of connective
tissues [1–2]. The process is initiated with the conversion of the specific telopeptidyl lysine
(Lys) and hydroxylysine (Hyl) residues to aldehyde (Lysald and Hylald, respectively) by a
copper-dependent amine oxidase, lysyl oxidase (EC 1.4.3.13, protein-lysine 6-oxidases,
LOX). The aldehyde produced then spontaneously interacts with the juxtaposed Lysald or ε-
amino groups of Lys or Hyl to form intra- and intermolecular cross-links [3]. LOX protein is
synthesized as a catalytically quiescent N-glycosylated ~50 kDa proLOX [4] by various cell
types and is processed extracellularly by bone morphogenetic protein (BMP)-1/mammalian
Tolloid-like proteins to produce an active mature ~30 kDa LOX [4]. The cleavage occurs
between residues Gly162 and Asp163 in mouse LOX (Gly168 and Asp169 in human LOX) [5–
6] possibly at the cell surface involving cellular fibronectin [7]. In this study, we report a
novel processing site of proLOX between Arg192 and Pro193 (numbered according to the
mouse sequence) resulting in a further truncated but active form of LOX (tLOX) that was
identified in a cell culture system as well as in bovine aorta.
MATERIALS & METHODS
All experiments were performed in accordance with the guidelines of the University of
North Carolina at Chapel Hill.
Cell Culture
Human embryonic kidney (HEK) 293 cells (Clontech) were maintained in Dulbecco’s
modified Eagle medium (Gibco) supplemented with 10% fetal bovine serum (Atlanta
Biologicals), 100 U/mL penicillin (Gibco), and 100 μg/mL streptomycin (Gibco) in a 5%
CO2 atmosphere at 37 °C. The medium was changed twice a week.
Generation of Stable Clones Overexpressing LOX
HEK 293 cells were stably transfected with a plasmid containing LOX coding sequences,
cultured and selected as described [8]. Briefly, PCR products were amplified using the
normal mouse kidney cDNA (BD Bioscience) as a template, purified and ligated into the
pcDNA3.1/V5-His-TOPO mammalian expression vector (Invitrogen), sequenced and the
plasmid containing LOX cDNA (pcDNA3.1/LOX/V5-His) was obtained. The sequences of
the primers were; forward primer, 5′-CCCGGTCTTCCTTTTTCTCCTAGCC-3′ and
reverse primer, 5′-ATACGGTGAAATTGTGCAGCCTGA-3′. HEK293 cells were
transfected with pcDNA3.1/LOX/V5-His as described [9] and cultured in the presence of
400 μg/mL of G418 (Gibco) for 3–4 weeks. The positive clones derived from single G418-
resistant cells were selected, cultured and the cultured media were subjected to
immunoprecipitation (IP) followed by Western blot (WB) analysis with anti(α)V5 antibody
(Invitrogen) [9] to verify the LOX-V5/His protein (LOX-V5).
Purification and Identification of LOX-V5 Protein
The 293-derived clones synthesizing the highest level of LOX-V5 protein were plated onto
15 cm plates, cultured for 6 days and the cultured media containing a cocktail of protease
inhibitors (Sigma) were collected. LOX-V5 was purified using a nickel-nitrotriacetic acid-
agarose resin (Qiagen) at 4°C, and the fractions immunoreactive to αV5 antibody were
pooled, dialyzed against 2 M urea then 0.2 M sodium borate pH 8.2, and kept at −80°C until
use. The protein concentrations were measured by a DC protein assay kit (Bio-Rad). To
assess the purity of LOX-V5, aliquots of the sample were subjected to 4–12% SDS-PAGE
under reducing conditions and stained with Coomassie Brilliant Blue (CBB) R-250 or WB
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analysis with αV5 antibody and two α LOX antibodies, αLOXi (Imgenex) and αLOXh [7–
8, 10].
Lysyl oxidase Activity Assay
The LOX enzyme activity was measured by the method reported by Palamakumbura and
Trackman [11] in the presence or absence of 500 μM β-aminopropionitrile (BAPN) using
F2000 spectrofluorometer (Hitachi).
LOX Protein Characterization by Mass Spectrometry
The major CBB stained protein bands at 30 and 35 kDa on the gel were cut, dehydrated and
digested with sequencing grade trypsin (Promega) in 50mM ammonium bicarbonate (Fisher
scientific) at 37°C overnight, using the automated in-gel digestion protocol described
previously [12]. For endoproteinase Asp N (AspN, P3303, Sigma-Aldrich) digestion, the
sample was dissolved in the same buffer and digested overnight at 35°C.
Mass Spectrometric Analysis and Database Searching
For protein identification from the gel bands, MALDI-MS and -MS/MS data were acquired
using an Applied Biosystems Voyager 4700 MALDI-TOF/TOF mass spectrometer (Applied
Biosystems, Inc.), in the positive ion reflectron mode. For the ABI TOF/TOF analyses, a
saturated solution of recrystallized α-cyano 4-hydroxycinnamic acid (Sigma-Aldrich) in
50:50 acetonitrile: 40 mM ammonium citrate/0.1% trifluoroacetic acid (TFA) was used as
the matrix solution. A 0.3 μL aliquot of each sample was spotted followed by 0.3 μL of
matrix solution, and allowed to dry at room temperature. MS and MS/MS spectra were
acquired in automated mode in which the 8 most intense peaks with a signal to noise ratio
greater than 25 were selected by the 4700 Data Explorer software for MS/MS analysis.
The peptide mass fingerprinting and sequence tag data from the TOF/TOF were evaluated
using AB’s GPS Explorer scores, which are derived from Mascot™ searches
(www.matrixscience.com). Ion Scores were generated by submitting MS/MS spectra to the
NCBI database via the Mascot search engine. Only proteins with Ion Scores greater than 20
were included in our analysis since those below 20 are not considered statistically significant
by Mascot. The following search conditions were used: variable modifications: methionine
oxidation, 2 missed cleavages, mass accuracy 100 ppm.
For the analysis of the enzymatic digests, samples were analyzed on a Bruker Ultraflex II,
operated in the positive ion reflectron mode. Samples were spotted as above, using a matrix
solvent consisting of recrystallized α-cyano 4-hydroxycinnamic acid in 50:50 ACN:water,
0.1% TFA.
Generation of Mutation and Deletion constructs of LOX
In order to obtain insights into the mechanism by which truncated LOX (tLOX) is generated,
several LOX constructs were generated and expressed in 293 cells. The constructs generated
were: 1. pcDNA3.1/LOX/V5-His (positive control), 2. pcDNA3.1/LOXD163>E, D164>G/
V5-His (LOX with double mutations at the cleavage site by BMP-1/mTLD like proteases
resulting in a non-processed proLOX) [13], and 3. pcDNA3.1/LOXΔPP/V5-His (LOX with
deletion of the propeptide domain) [14]. An empty vector (pcDNA3.1/V5-His) was used as a
negative control. To generate the mutation/deletion constructs, the following additional
primers were used. For pcDNA3.1/LOXD163>E, D164>G/V5-His: forward primer, 5′-
CATGGTGGGCGAAGGCCCTACAATC-3′ and 5′-
GATTGTAGGGGCCTTCGCCCACCATG-3′, and for pcDNA3.1/LOXΔPP/V5-His:
forward primer, 5′-CTTCTCCGCTGCGACGACCCCTACAATCCCTAC-3′ and reverse
primer, 5′-GTAGGGATTGTAGGGGTCGTCGCAGCGGAGAAG-3′. The PCR product
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was subcloned into the pcDNA3.1/V5-His-TOPO mammalian expression vector and
sequenced at the UNC-CH DNA sequencing facility. 293 cells were transfected with 2.5 μg
of each construct, or an empty vector. At 72 hours after transfection, the cultured medium
was collected and subjected to IP-WB analysis with αV5 antibody [8].
Isolation of Bovine Lysyl oxidase
Lysyl oxidase was isolated from bovine aorta by the method reported by Kagan and Cai [15]
with some modifications. All preparations and purification were performed at 4°C in the
presence of a cocktail of protease inhibitors (Sigma-Aldrich). Bovine aorta was cut into
small pieces and pulverized in liquid nitrogen by a Spex Freezer Mill (Spex Certiprep) and
washed by repeated centrifugation (X10,000g for 30min) with 0.4 M NaCl, 16 mM
potassium phosphate pH 7.8, then with 16 mM potassium phosphate pH 7.8. The residues
were extracted with 4 M urea, 16 mM potassium phosphate, pH 7.8 for 3 days, the
supernatant was collected by centrifugation and this process was repeated twice. The
supernatants pooled were then mixed with pre-equilibrated Bio-Gel HTF hydroxyapatite
(Bio-Rad) for 30 min at 4°C. The supernatant was collected by centrifugation and
concentrated by a ultrafiltration cell with a YM10 ultrafiltration membrane (Amicon). The
concentrated extract was dialyzed exhaustively against 16 mM potassium phosphate, an
equal volume of 1 M potassium phosphate, pH 7.8, was added and the precipitate was
collected by centrifugation. The precipitate was dissolved in 6M urea, 16 mM potassium
phosphate, pH 7.8 and separated on a Superdex 200 column (HiLoad 16/60, GE
healthsciences) equipped with a Varian ProSatr HPLC system using the same buffer and the
eluate was collected. An aliquot of each fraction was subjected to amine oxidase activity
assay [11], the enzymatically active fractions were collected and pooled. The pooled
samples were further dialyzed against 2 M urea, 16 mM potassium phosphate, pH 7.8 and
separated on an anion exchange column (Protein-Pak DEAE 8HR, Waters) eluting with the
same buffer with a gradient of 0 to 1M NaCl. An aliquot from every other fraction was
subjected to amine oxidase activity assay and the relative fluorescence values were plotted.
Two more aliquots from each fraction were also subjected to WB analysis with αLOXi and
αLOXh antibodies respectively.
RESULTS
Identification, Characterization and Enzymatic Activity of LOX-V5 Protein
The purified mouse LOX-V5 protein was first characterized by SDS-PAGE and WB
analyses. The results were consistent with our recent report [8]. When stained with CBB,
two major protein bands at ~30 and 35 kDa, respectively, and a faint band at ~48 kDa were
observed (Fig 1A, lane 1). By WB analyses with αV5 antibody (Fig. 1A, lane 3) and two
αLOX antibodies (αLOXi and αLOXh) (Fig. 1A, lanes 4 and 5, respectively), the 30 kDa
protein was immunopositive only to αV5 and αLOXi antibodies, but the 35 kDa band to all
3 antibodies (αV5, αLOXh and αLOXi antibodies). The ~48 kDa band was also
immunopositive to all 3 antibodies. When the protein was incubated with normal rabbit
serum, no immunoreactivity was detected (Fig. 1A, lane 2). The 48 kDa protein is likely
full-length LOX as previously reported [4]. Then the protein was subjected to the amine
oxidase assay (Fig 1B). The activity was readily detected and increased with dose, but was
nullified by the addition of 500μM BAPN. These results demonstrate that the recombinant
LOX-V5 generated is active as an amine oxidase.
The major mouse LOX-V5 bands migrated at 35 and 30 kDa were excised from the gel and
subjected to MALDI-MS and MALDI-MS/MS analyses at the UNC-Duke Proteomics
Center. Four tryptic peptides from the 35 kDa band (aa 225–231, 246–254, 263–277, and
372–391), and three from the 30 kDa band (aa 225–231, 263–277, 372–391) were identified
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as mouse LOX peptides (accession protein# NP_034858.1), thus, confirming both proteins
as mouse LOX. The gel extracts from 30 and 35 kDa mouse LOX-V5 bands were further
characterized to identify a proteolytic cleavage site by MALDI-MS on a Bruker Ultraflex II
mass spectrometer. The relevant peptides identified are summarized in Table 1 and Fig 1C.
The tryptic fragments, T1 and 2 (the first and second tryptic peptides from the N-terminus of
mature LOX-V5), were identified in gel extracts from the 35 kDa band, but not from the 30
kDa band (Table 1, Fig 1C). A tryptic peptide, T3, including the N-terminal asparagine (N)-
arginine (R)192 sequence was also found in the 35 kDa LOX-V5. The C-terminal of R192
was not cleaved by trypsin due to the presence of proline (P) located C-terminal to this
residue [16]. The T3 was also identified from the 30 kDa band but the the N-terminal NR192,
was missing, thus, designated as T3 (partial). However, in some cases, the peptide bond
between R and P could be cleaved by trypsin [17]. Thus, to determine whether or not the
carboxy terminus of Arg192 is the actual proteolytic cleavage site, the 30 and 35 kDa mouse
LOX-V5 protein bands excised from the gel were manually digested with AspN. The
resulting MALDI-MS spectra from AspN digestion from 1600 to ~2600 m/z are shown on
the right panel in Fig. 1C. The peak at m/z 2625.30 in the AspN digest of 35kDa LOX-V5
(upper spectra) corresponds to the calculated m/z for ERPRPGSRNRPGYGTGYFQYGLP
(AspN6, Table 1) (see also peptide illustration below the spectra in Fig 1C) where the
cleavage occurred at the N-terminus of glutamic acid (E) [18]. This peak was not found in
the AspN digest of the 30kDa LOX-V5 (lower spectra). Instead, there was a new peak at m/
z 1689.84 (lower spectra), which corresponds to the calculated molecular weight for
NRPGYGTGYFQYGLP (designated as AspN6 partial in Table 1 and Fig 1C), the N-
terminus of which is a non-AspN cleavage site. These results strongly indicate that this is
the N-terminus of the 30 kDa mouse LOX with a novel proteolytic cleavage site, the C
terminus of Arg192. The AspN1–5 fragments were all identified in the 35 kDa band but not
in the 30 kDa band (Table 1) (also, see peptide illustration in Fig 1C).
Transfection and mRNA Expression of Deletion Mutation LOX
In order to determine if the presence of propeptide or BMP-1 processing is involved in the
generation of tLOX, we generated full-length LOX (Fig 2, left panel, construct 1), full-
length LOX with point mutations induced at the BMP-1 cleavage site (LOXΔBMP-1) (Fig.
2, construct 2), and mature LOX (signal peptide and mature LOX: residue 1–16 and 163–
411, mLOX) (Fig. 2, construct 3). The protein expression was assessed by IP-WB analysis
(Fig 2, right panel). In Ev (negative control), an IgG heavy chain indicated by an asterisk
was observed at ~50 kDa. When full-length LOX was expressed, both 35 and 30 kDa mature
LOX proteins were identified (lane 1). The full-length LOX (proLOX) band was observed at
~48 kDa partially overlapping with an IgG heavy chain. The full length LOX construct
devoid of the BMP-1 cleavage site (LOXΔBMP-1, construct 2) did not produce the 35 kDa
LOX but the 30 kDa LOX was detected (lane 2) indicating that this novel processing is not
dependent on the processing by BMP-1. However, when the propeptide was absent, the 35
kDa LOX but not the 30 kDa LOX was detected, (lane 3) indicating the critical importance
of the propeptide for the novel processing.
The Presence of the Novel Processing of LOX in Bovine Aorta
In order to investigate if the novel processing occurs in vivo, LOX was isolated from bovine
aorta. The enzymatically active fractions pooled from the initial molecular sieve
chromatography were subjected to DEAE column chromatography and the fractions
collected were analyzed for amine oxidase activity (solid bars in Fig 3) and
immunoreactivities with αLOXi and αLOXh antibodies (two panels below the
chromatograph, Fig 3). Two enzymatically active peaks were identified, one passed through
the column (peak I) and the other eluted with a NaCl concentration of >0.4M (peak II) (Fig.
3). With WB analysis, both ~25 and ~30 kDa immunoreactive bands were detected with
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αLOXi antibody (upper panel) that corresponded to the enzymatically active peaks I and II,
respectively. However, with αLOXh antibody, only ~30 kDa band, but not the 25 kDa band,
was detected (lower panel). These two immunoreactive, enzymatically active bovine LOX
proteins (I and II) well correspond to the two molecular species of LOX-V5 proteins
expressed by 293 cells in terms of the molecular size (30 and 35 kDa with a ~5 kDa V5 tag)
as well as the pattern of immunoreactivity.
DISCUSSION
It has been well documented that pro LOX is processed by PCP/BMP-1 [5–6] and other
extracellular proteases including tolloid-like-1 and 2 proteases (mTLL-1 and -2) [19]
between Gly162 and Asp163 (numbered according to the mouse sequence). In our recent
report, we noted that two molecular species of mature LOX may exist [8]. In the current
study, we have identified a truncated form of mature LOX (tLOX) from a cell culture
system as a ~30kDa LOX-V5 recombinant protein and as a ~25kDa LOX protein from
bovine aorta. tLOX is a novel proteolytic product of proLOX between Arg192 and Asn193
and appears to retain amine oxidase activity. Interestingly, tLOX was immunoreactive with
αLOXi but not αLOXh. This can be explained by the specific epitopes for the respective
antibodies. The peptide sequence used to generate αLOXi antibody is residues 305–320
(DLLDANTQRRVAEGHK) (RES # 305–320 in human LOX) located near the C terminus
of LOX while that for αLOXh antibody is residues 176–197
(KYSDDNPYYNYYDTYERPRPGG) which is near the PCP/BMP-1 cleavage site, thus
near the N-terminus, of human LOX [7, 10]. The difference between LOX and tLOX is the
presence or absence of the residues 163–192 (DDPYNPYKYS/
TDDNPYYNYYDTYERPRPGSR) (RES # 179–198 in human LOX) where the epitope for
the αLOXh antibody resides. This is most likely the reason for the lack of immunoreactivity
of tLOX with αLOXh antibody. The biological significance of the presence or absence of
this peptide is not clear at present. However, the relative abundance of acidic amino acid
residues in this peptide could be important for the substrate specificity, protein binding,
stability and folding. The lack of this acidic peptide in tLOX could be the reason why it
failed to bind to anionic exchange resin while LOX did (Fig 3). Interestingly, the
DDPYNPYKYS(T)DDNPY sequence in this peptide is similar to the
DDPYDPYPYEPYEPY sequence in the N-terminal region of fibromodulin, a collagen-
binding small leucine-rich proteoglycan. Some of the Tyr residues in this sequence of
fibromodulin have been reported to be sulfated [20]. Though we failed to identify the
tyrosine sulfation in LOX by MALDI-MS analysis, this could be due to the lability of this
modification under the conditions used [20–23]. Further studies are warranted to investigate
this potential modification in LOX and its significance.
It has been reported that, beside PCP/BMP-1, proLOX can be also processed by MMP-2 at
the specific site in the propeptide region. In the current study, the MMP-2 processed LOX
resulting from the cleavage between Asn and Leu [6] was not observed. This might be due
to the difference in the cell type and vectors for the generation of recombinant LOX. In the
system reported in this study, the LOX-V5 protein secreted is processed and enzymatically
active [8]. This is also different from the recombinant LOX protein generated in S4 cells in
which it is secreted as a proLOX and cannot be further processed [4, 6].
This study is the first to show this novel processing that results in producing an
enzymatically active 25 kDa LOX both in a cell culture system and bovine aorta. This novel
processing requires an unknown serine protease, which might bind to LOX propeptide in
order to process proLOX between R192 and D193 (mouse sequence) since the deletion of the
LOX propeptide prevents this novel processing.
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Characterization of a novel processing of proLOX. A. SDS-PAGE and Western blot
analysis. Purified LOX-V5 protein was subjected to SDS-PAGE analysis stained with
Coomassie Brilliant Blue (CBB) (lane 1) and WB analysis with normal rabbit serum (NRS)
(lane 2), anti(α)(V5 antibody (lane 3), αLOXi antibody (Imgenex) (lane 4) and αLOXh
antibody (lane 5). Two major CBB stained bands were observed at ~30 and ~35 kDa bands.
Both proteins are immunoreactive with αV5 (lane 3) and αLOXi (lane 4) antibodies but
only the ~35kDa band was immunoreactive with αLOXh antibody (lane 5). No
immunoreactivity was found with NRS (lane 2). B. Amine oxidase activity of LOX-V5
protein. Note that the amine oxidase activity of LOX-V5 protein is retained and increased in
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a dose-dependent manner, and the activity was nullified by 500 μM of BAPN. C. Upper
panel: MALDI-MS spectra from the tryptic (T) and AspN digestion of the 35 kDa (mature)
and 30 kDa (truncated) LOX-V5. T1, T2 and T3 were identified in the 35kDa LOX-V5,
while in the 30 kDa LOX-V5 only a shorter form of T3, denoted as T3 (partial), was
identified. In the AspN digests, a shorter form of AspN6, AspN6 (partial), was found only in
the 30kDa LOX-V5. The peptides identified by mass spectrometry (T1–3, partial T3,
AspN1–6, partial AspN6) are illustrated in the lower panel. The residue numbers are based
on the mouse proLOX. For the detailed information about each peptide, see Table 1.
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Generation of LOX constructs and their expression pattern. Three LOX-V5 constructs were
generated and shown on left. 1. LOX-V5, 2: LOX(D163D164>EG)-V5, 3: ΔPPLOX-V5
(lacking propeptide). The protein expression of each construct was analyzed by IP-WB with
αV5 antibody and shown on right. An asterisk at ~50 kDa indicates IgG heavy chain. Ev:
Control cells transfected with an empty vector (negative control). Lane 1: LOX-V5, lane 2:
LOX(D163D164>EG)-V5, lane 3: ΔPPLOX-V5. When LOX-V5 was expressed, a full-length
(~48kDa just below the IgG heavy chain), a mature LOX-V5 (35 kDa) and a truncated
LOX-V5 (30 kDa) were observed (lane 1). With LOXΔPCP expression, full-length (50kDa)
and a truncated LOX-V5 (30 kDa) but not mature LOX-V5 (35 kDa) were observed (35
kDa) (lane 2). With ΔPPLOX, only mature LOX (35 kDa) was observed (lane 3)
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DEAE chromatograph of bovine aorta derived LOX. Upper panel: the solid line represents
the amine oxidase activity in the fractions and the dotted line the percentage of 1M NaCl.
Lower panel: Western blot analyses of the fractions with anti(α)LOXi (upper section) and
αLOXh antibody (lower section). The unbound fractions (peak I) contained tLOX (25 kDa)
which was immunoreactive only with αLOXi but not with αLOXh while the bound
fractions (peak II) contained mature bovine LOX (30 kDa) which was immunoreactive with
both αLOXi and αLOXh.
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